5 years ago

Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia [Medical Sciences]

Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia [Medical Sciences]
Marius Bill, Damian J. Steiner, Deedra Nicolet, Betina McNeil, Guido Marcucci, Krzysztof Mrozek, Carlo M. Croce, Michael A. Caligiuri, Matthew H. Burke, Nina Zitzer, Jonathan E. Kolitz, Ramiro Garzon, Clara D. Bloomfield, Selen A. Yilmaz, Bayard L. Powell, Eunice S. Wang, Changxian Shen, Malith Karunasiri, Hatice Gulcin Ozer, Adrienne M. Dorrance, Christopher C. Oakes, Dimitrios Papaioannou, Thomas H. Carter, Gregory K. Behbehani

Epithelial growth factor-like 7 (EGFL7) is a protein that is secreted by endothelial cells and plays an important role in angiogenesis. Although EGFL7 is aberrantly overexpressed in solid tumors, its role in leukemia has not been evaluated. Here, we report that levels of both EGFL7 mRNA and EGFL7 protein are increased in blasts of patients with acute myeloid leukemia (AML) compared with normal bone marrow cells. High EGFL7 mRNA expression associates with lower complete remission rates, and shorter event-free and overall survival in older (age ≥60 y) and younger (age <60 y) patients with cytogenetically normal AML. We further show that AML blasts secrete EGFL7 protein and that higher levels of EGFL7 protein are found in the sera from AML patients than in sera from healthy controls. Treatment of patient AML blasts with recombinant EGFL7 in vitro leads to increases in leukemic blast cell growth and levels of phosphorylated AKT. EGFL7 blockade with an anti-EGFL7 antibody reduced the growth potential and viability of AML cells. Our findings demonstrate that increased EGFL7 expression and secretion is an autocrine mechanism supporting growth of leukemic blasts in patients with AML.

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.